Ann: Mesoblast Phase 3 Chronic Heart Failure Results, page-389

@optimistus
if you can't see the potential in these results ... then it may not be the right company for you to be invested in. Don't think you need someone on a forum to make these decisions up for you... maybe you do?

it's a journey that most companies end up going bust before they even get to read-out their phase 3 results... we've just completed the world's largest ever stem cell trial in the cardiovascular space.. the FDA could give accelerated approval a nod, they've never seen data like this before.. so nobody really knows... and it's now up to a large pharma to pick this up and finish off the job, run that confirmatory trial which will.. guess what, take more time and a lot more money.

if you are more interested in what will bring in revenue quickest... look no further than COVID ARDS / all-cause ARDS.. it's already partnered up and reading out shortly. Ryoncil is also still in with a chance for accelerated approval.